Regarding the possible pathophysiology, it has been recognized that the immune response activated by intermittent hypoxia probably contributes to the rising inflammatory biomarkers in OSA patients, which attributes to the activation of nuclear factor-κB (NF‐κB) pathways [28, 29]. The gene discussed is NFKB1; the disease is obstructive sleep apnea syndrome.